Trypanosoma cruzi: Does the intake of nanoencapsulated benznidazole control acute infections?-Reference-Cited by-同舟云学术

Trypanosoma cruzi: Does the intake of nanoencapsulated benznidazole control acute infections?

Published:2023-06 Issue: Volume:249 Page:108520
ISSN:0014-4894
Container-title:Experimental Parasitology
language:en
Short-container-title:Experimental Parasitology

Author:

Dutra da Silva Aniélen,Fracasso Mateus,Bottari Nathieli B.,Gundel Samanta,Ourique Aline F.,Assmann Charles E.,Ferreira Danielle A.S.P.,Castro Milagros F.V.,Reichert Karine P.,de Souza Lucas A.F.,da Veiga Marcelo L.,da Rocha Maria Izabel U.M.,Monteiro Silvia G.,Morsch Vera M.,Chitolina Schetinger Maria Rosa,da Silva Aleksandro S.

Publisher

Elsevier BV

Subject

Immunology,General Medicine,Parasitology,Infectious Diseases

Reference29 articles.

1. Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection;Abriata;Mater. Sci. Eng. C,2017

2. The use of solid dispersion systems in hydrophilic carriers to increase benznidazole solubility;Ádley;J. Pharmaceut. Sci.,2011

3. Treatment of chagas disease;Apt;American Trypanosomiasis Chagas Disease,2017

4. Parasitologia - fundamentos e Prática Clínica. 1°ed., Guanabara Koogan. Grupo GEN.;Batista,2020

5. Sesquiterpene lactone in nanostructured parenteral dosage form is efficacious in experimental chagas disease;Branquinho;Antimicrob. Agents Chemother.,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What are the translational challenges associated with Chagas disease drug discovery?;Expert Opinion on Drug Discovery;2024-09-13

2. Nanomedicines against Chagas disease: a critical review;Beilstein Journal of Nanotechnology;2024-03-27